Ads
related to: black women's health study breast cancer risk assessment tool army- HR+ HER2- mBC Treatment
Find Out More Information About
An HR+ HER2- mBC Treatment.
- mBC Treatment Option
Visit The Site To View Treatment
Info & Patient Resources.
- Financial Support Info
See The Financial Resources
For A mBC Treatment.
- Patient Support Program
Learn About A Patient Support
Program For A mBC Treatment.
- HR+ HER2- mBC Treatment
myriad.com has been visited by 10K+ users in the past month
Search results
Results From The WOW.Com Content Network
The Tyrer-Cuzik Model and the Black Women's Health Study (BWHS) Breast Cancer Risk Calculator also include race and ethnicity in the assessment. The BOADICEA calculates risk for breast and for ...
The Black Women’s Health Study Breast Cancer Risk Calculator launched in 2021 and estimates short-term risk for women between the ages of 30 and 70. It gave me a 10-year risk of 0.8%, compared ...
A number of different tools exist, but the two most commonly used ones are the Breast Cancer Risk Assessment Tool (BCRAT, formerly called the “Gail Model”) and the International Breast Cancer ...
The Black Women's Health Study (BWHS) is a long-term observational study conducted at Boston University's Slone Epidemiology Center since 1995 to investigate the health problems of black women over a long time period, with the ultimate goal of improving their health. Gaining information about the causes of health problems that affect black ...
The NCI (National Cancer Institute) provides a free breast cancer risk assessment tool online that utilizes the Gail Model to predict risk of developing invasive breast cancer based on a woman's personal information. [43] This tool has been found to underestimate the risk of breast cancer in non-white women. [43]
The Women's Health Initiative (WHI) was a series of clinical studies initiated by the U.S. National Institutes of Health (NIH) in 1991, to address major health issues causing morbidity and mortality in postmenopausal women. It consisted of three clinical trials (CT) and an observational study (OS).